DR. NGOZI ERONDU, MD
Osteopathic Medicine at Baird Rd, Millstone Township, NJ
License number
New Jersey MA072304
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
63 Baird Rd, Millstone Township, NJ 08535
Phone
(908) 816-1233
Professional information
Combination Therapy For The Treatment Of Hypertension
US Patent:
2006016, Jul 20, 2006
Filed:
Jun 2, 2004
Appl. No.:
10/559111
Inventors:
Tung Fong - Somerset NJ, US
Ngozi Erondu - Englishtown NJ, US
Douglas MacNeil - Westfield NJ, US
James McIntyre - Piscataway NJ, US
Leonardus Van Der Ploeg - Lansdale PA, US
Ngozi Erondu - Englishtown NJ, US
Douglas MacNeil - Westfield NJ, US
James McIntyre - Piscataway NJ, US
Leonardus Van Der Ploeg - Lansdale PA, US
International Classification:
A61K 31/4747, A61K 31/353, A61K 31/155
US Classification:
514278000, 514454000, 514635000
Abstract:
The present invention relates to compositions comprising an anti-obesity agent and an anti-hypertensive agent useful for the treatment of hypertension, hypertension associated with obesity, and hypertension-related disorders. The present invention further relates to methods of treating or preventing obesity, and obesity-related disorders, in a subject in need thereof by administering a composition of the present invention. The present invention further provides for pharmaceutical compositions, medicaments, and kits useful in carrying out these methods.
Combination Therapy For The Treatment Of Diabetes
US Patent:
2007009, May 3, 2007
Filed:
Jun 2, 2004
Appl. No.:
10/559206
Inventors:
Ngozi Erondu - Englishtown NJ, US
Tung Fong - Somerset NJ, US
Akio Kanatani - Ushiku-shi, JP
Douglas MacNeil - Westfield NJ, US
Leonardus Van Der Ploeg - Lansdale PA, US
Tung Fong - Somerset NJ, US
Akio Kanatani - Ushiku-shi, JP
Douglas MacNeil - Westfield NJ, US
Leonardus Van Der Ploeg - Lansdale PA, US
International Classification:
A61K 31/498, A61K 31/4747, A61K 31/4196, A61K 31/353
US Classification:
514183000, 514278000, 514454000, 514249000, 514383000
Abstract:
The present invention relates to compositions comprising an anti-obesity agent and an anti-diabetic agent useful for the treatment of diabetes, diabetes associated with obesity and diabetes-related disorders. The present invention further relates to methods of treating or preventing obesity, and obesity-related disorders, in a subject in need thereof by administering a composition of the present invention. The present invention further provides for pharmaceutical compositions, medicaments, and kits useful in carrying out these methods.
Combination Therapy For The Treatment Of Obesity
US Patent:
2008006, Mar 13, 2008
Filed:
Sep 22, 2005
Appl. No.:
11/661960
Inventors:
John Amatruda - New York NJ, US
Paul Daruwala - Branchburg NJ, US
Ngozi Erondu - Englishtown NJ, US
Douglas MacNeil - Westfield NJ, US
David Moller - Bedminster NJ, US
Su Qian - Princeton NJ, US
Paul Daruwala - Branchburg NJ, US
Ngozi Erondu - Englishtown NJ, US
Douglas MacNeil - Westfield NJ, US
David Moller - Bedminster NJ, US
Su Qian - Princeton NJ, US
International Classification:
A61K 38/17, A61P 3/04
US Classification:
514012000
Abstract:
The present invention relates to compositions comprising PYY, PYY, or a PYY agonist, and an anti-obesity agent, useful for the treatment and prevention of obesity and obesity-related disorders. The present invention further relates to methods of treating or preventing obesity and obesity-related disorder in a subject in need thereof by administering a composition of the present invention. The present invention further provides for pharmaceutical compositions, medicaments, and kits useful in carrying out these methods.
Combination Therapy For The Treatment Of Dyslipidemia
US Patent:
2006014, Jul 6, 2006
Filed:
Jun 2, 2004
Appl. No.:
10/555194
Inventors:
Ngozi Erondu - Englishtown NJ, US
International Classification:
A61K 31/506, A61K 31/497, A61K 31/7024, A61K 31/4747, A61K 31/353
US Classification:
514023000, 514255050, 514278000, 514256000, 514454000
Abstract:
The present invention relates to compositions comprising an anti-obesity agent and an anti-dyslipidemic agent useful for the treatment of dyslipidemia, dyslipidemia associated with obesity and dyslipidemia-related disorders. The present invention further relates to methods of treating or preventing obesity, and obesity-related disorders, in a subject in need thereof by administering a composition of the present invention. The present invention further provides for pharmaceutical compositions, medicaments, and kits useful in carrying out these methods.